Initial cognitive decline is associated with cortical thinning in early Parkinson disease

Objectives: Our aim was to assess cortical thickness in a large multicenter cohort of drug-naive patients with early Parkinson disease (PD), with and without mild cognitive impairment (MCI), and explore the cognitive correlates of regional cortical thinning. Methods: One hundred twenty-three newly diagnosed patients with PD and 56 healthy controls with 3-tesla structural MRI scans and complete neuropsychological assessment from the Parkinson's Progression Markers Initiative were included. Modified Movement Disorders Society Task Force level II criteria were applied to diagnose MCI in PD. FreeSurfer image processing and analysis software was used to measure cortical thickness across groups and the association with cognitive domains and tests. Results: In patients with MCI, atrophy was found in temporal, parietal, frontal, and occipital areas compared with controls. Specific regional thinning in the right inferior temporal cortex was also found in cognitively normal patients. Memory, executive, and visuospatial performance was associated with temporoparietal and superior frontal thinning, suggesting a relationship between cognitive impairment and both anterior and posterior cortical atrophy in the whole patient sample. Conclusions: These findings confirm that MCI is associated with widespread cortical atrophy. In addition, they suggest that regional cortical thinning is already present at the time of diagnosis in patients with early, untreated PD who do not meet the criteria for MCI. Together, the results indicate that cortical thinning can serve as a marker for initial cognitive decline in early PD.

[1]  N. Bargalló,et al.  Combined dementia-risk biomarkers in Parkinson's disease: a prospective longitudinal study. , 2013, Parkinsonism & related disorders.

[2]  D. Burn,et al.  Magnetic resonance imaging: A biomarker for cognitive impairment in Parkinson's disease? , 2013, Movement disorders : official journal of the Movement Disorder Society.

[3]  Mojtaba Zarei,et al.  Cortical thinning is associated with disease stages and dementia in Parkinson's disease , 2013, Journal of Neurology, Neurosurgery & Psychiatry.

[4]  J. Kulisevsky,et al.  Pattern of Regional Cortical Thinning Associated with Cognitive Deterioration in Parkinson’s Disease , 2013, PloS one.

[5]  E. Tolosa,et al.  Grey matter volume correlates of cerebrospinal markers of Alzheimer-pathology in Parkinson's disease and related dementia. , 2012, Parkinsonism & related disorders.

[6]  P. Svenningsson,et al.  Cognitive impairment in patients with Parkinson's disease: diagnosis, biomarkers, and treatment , 2012, The Lancet Neurology.

[7]  Eric Westman,et al.  Combining MRI and CSF measures for classification of Alzheimer's disease and prediction of mild cognitive impairment conversion , 2012, NeuroImage.

[8]  J. Kulisevsky,et al.  Cognitive impairment and dementia in Parkinson's disease , 2012, Neurobiology of Disease.

[9]  R. Barker,et al.  Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines , 2012, Movement disorders : official journal of the Movement Disorder Society.

[10]  P. Moberg,et al.  Neurodegeneration across stages of cognitive decline in Parkinson disease. , 2011, Archives of neurology.

[11]  A. Singleton,et al.  The Parkinson Progression Marker Initiative (PPMI) , 2011, Progress in Neurobiology.

[12]  T. Anderson,et al.  Grey matter atrophy in cognitively impaired Parkinson's disease , 2011, Journal of Neurology, Neurosurgery & Psychiatry.

[13]  A. Simmons,et al.  Combining MRI and CSF measures for classification of Alzheimer's disease and prediction of mild cognitive impairment conversion , 2011, Alzheimer's & Dementia.

[14]  Constantinos Kallis,et al.  Lewy- and Alzheimer-type pathologies in Parkinson's disease dementia: which is more important? , 2011, Brain : a journal of neurology.

[15]  Hae-Jeong Park,et al.  The pattern of cortical atrophy in patients with Parkinson's disease according to cognitive status , 2011, Movement disorders : official journal of the Movement Disorder Society.

[16]  Magda Tsolaki,et al.  The AddNeuroMed framework for multi‐centre MRI assessment of Alzheimer's disease : experience from the first 24 months , 2011, International journal of geriatric psychiatry.

[17]  Angie A. Kehagia,et al.  Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson's disease , 2010, The Lancet Neurology.

[18]  Y. Sohn,et al.  Neuroanatomic basis of amnestic MCI differs in patients with and without Parkinson disease , 2010, Neurology.

[19]  R. Barker,et al.  Mild cognitive impairment in Parkinson disease , 2010, Neurology.

[20]  Y. Itoyama,et al.  Corticolimbic gray matter loss in Parkinson’s disease without dementia , 2010, European journal of neurology.

[21]  E. Tolosa,et al.  Differential progression of brain atrophy in Parkinson's disease with and without visual hallucinations , 2009, Journal of Neurology, Neurosurgery & Psychiatry.

[22]  Thomas Foltynie,et al.  The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort. , 2009, Brain : a journal of neurology.

[23]  E. Tolosa,et al.  Neuroanatomical substrate of visuospatial and visuoperceptual impairment in Parkinson's disease , 2009, Movement disorders : official journal of the Movement Disorder Society.

[24]  David Bartrés-Faz,et al.  Structural brain correlates of verbal fluency in Parkinson's disease , 2009, Neuroreport.

[25]  D. Aarsland,et al.  Cognitive impairment in incident, untreated Parkinson disease , 2009, Neurology.

[26]  R. Camicioli,et al.  Voxel-based morphometry reveals extra-nigral atrophy patterns associated with dopamine refractory cognitive and motor impairment in parkinsonism. , 2009, Parkinsonism & related disorders.

[27]  E. Tolosa,et al.  Diagnostic procedures for Parkinson's disease dementia: Recommendations from the movement disorder society task force , 2007, Movement disorders : official journal of the Movement Disorder Society.

[28]  T. Robbins,et al.  Evolution of cognitive dysfunction in an incident Parkinson's disease cohort. , 2007, Brain : a journal of neurology.

[29]  J. Jankovic,et al.  Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): Process, format, and clinimetric testing plan , 2007, Movement disorders : official journal of the Movement Disorder Society.

[30]  M. Corbetta,et al.  Control of goal-directed and stimulus-driven attention in the brain , 2002, Nature Reviews Neuroscience.

[31]  Alex Martin,et al.  Semantic memory and the brain: structure and processes , 2001, Current Opinion in Neurobiology.

[32]  A M Dale,et al.  Measuring the thickness of the human cerebral cortex from magnetic resonance images. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[33]  A. Dale,et al.  Cortical Surface-Based Analysis II: Inflation, Flattening, and a Surface-Based Coordinate System , 1999, NeuroImage.

[34]  Anders M. Dale,et al.  Cortical Surface-Based Analysis I. Segmentation and Surface Reconstruction , 1999, NeuroImage.

[35]  J. Yesavage,et al.  Geriatric Depression Scale (GDS): Recent evidence and development of a shorter version. , 1986 .

[36]  M. Hoehn,et al.  Parkinsonism , 1967, Neurology.

[37]  C. Davatzikos,et al.  Alzheimer's disease pattern of brain atrophy predicts cognitive decline in Parkinson's disease. , 2012, Brain : a journal of neurology.

[38]  D. Aarsland,et al.  Verbal memory in drug-naive, newly diagnosed Parkinson's disease. The retrieval deficit hypothesis revisited. , 2011, Neuropsychology.

[39]  Nikos Makris,et al.  Automatically parcellating the human cerebral cortex. , 2004, Cerebral cortex.

[40]  S Fahn,et al.  Committee. Unified Parkinson’s Disease Rating Scale. , 2001 .

[41]  A. Bonnet,et al.  [The Unified Parkinson's Disease Rating Scale]. , 2000, Revue neurologique.